Failure of Systemic Propranolol Therapy for Choroidal Hemangioma of Sturge-Weber Syndrome A Report of 2 Cases

Krema H, Yousef YA, Durairaj P, et al. — Wed, 01 May 2013 00:00:00 GMT

Propranolol was incidentally discovered to induce accelerated involution of infantile cutaneous hemangioma. Thereafter, reports have demonstrated a favorable response to propranolol as a first-line treatment for cutaneous, orbital, and ocular hemangioma in different ages. We report the outcome of oral propranolol therapy in 2 cases with choroidal hemangioma of Sturge-Weber syndrome (SWS).

AMA Publishing Group: Hemangiomas Topic Collection

Failure of Systemic Propranolol Therapy for Choroidal Hemangioma of Sturge-Weber Syndrome A Report of 2 Cases